Selena Gomez took to the American Music Awards (AMAs) stage for the first time in two years on Sunday night to perform two new tracks, ‘Lose You To Love Me’ and ‘Look At Her Now’.
However, the 27-year-old singer was criticised for her vocals during her set with some people claiming she sounded “shaky” and “off-key”.
Selena’s fans rushed to defend her, saying she reportedly had a lupus flare up and an anxiety attack before going on stage, which was why it “wasn’t her best performance”.
Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.